Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 17/20 | 0.72 |
| ▸ | CDK1 | P06493 | 7/20 | 0.72 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.51 |
| ▸ | SYK | P43405 | 2/20 | 0.48 |
| ▸ | CDK4 | P11802 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1449343 | 0.97 | CDK2 (0.77) | CDK2CDK1KCNH2SYKCDK4 | |
| SCHEMBL1447207 | 0.92 | CDK2 (0.68) | CDK2CDK1KCNH2SYKCDK4 | |
| SCHEMBL1448127 | 0.88 | CDK2 (0.71) | CDK2CDK1KCNH2SYKCDK4 | |
| SCHEMBL1447698 | 0.88 | CDK2 (0.93) | CDK2CDK1KCNH2CDK4 | |
| SCHEMBL1447799 | 0.87 | CDK2 (0.66) | CDK2CDK1KCNH2SYKCDK4 | |
| SCHEMBL1447679 | 0.85 | CDK2 (0.73) | CDK2CDK1KCNH2SYK | |
| SCHEMBL1448282 | 0.84 | CDK2 (0.59) | CDK2CDK1KCNH2SYKCDK4 | |
| SCHEMBL1448230 | 0.84 | CDK2 (1.00) | CDK2CDK1KCNH2CDK4 | |
| SCHEMBL1448435 | 0.82 | CDK2 (0.57) | CDK2CDK1KCNH2SYKCDK4 | |
| SCHEMBL1447640 | 0.81 | CDK2 (0.78) | CDK2CDK1KCNH2SYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2301928-A1 | Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders | AstraZeneca AB (SE) | 2011-03-30 | — | — | EP | disclosed |